The impact of a best practice advisory for shifting to oral medications: A quality improvement project
- 18 July 2025
- journal article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 20 (12) , 1377-1382
Abstract
We developed a Best Practice Advisory (BPA) to encourage switching from intravenous (IV) to oral (PO) formulations of antimicrobials with equal efficacy, to decrease costs and IV usage. We conducted a prospective study analyzing our BPA's effect on prescribing practices of antimicrobials in the inpatient setting of Stanford Hospital in Palo Alto, CA, over a 22‐month period. Our BPA achieved a 1526/6585 (23.2%) acceptance rate and led to decreased use of IV antimicrobials, with substantial direct cost savings of at least $66,976. Future efforts will focus on expanding our BPA to non‐antimicrobials given ongoing IV fluid shortages.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (T32 AI007502)
This publication has 7 references indexed in Scilit:
- Early Switch From Intravenous to Oral Antibiotics for Patients With Uncomplicated Gram-Negative BacteremiaJAMA Network Open, 2024
- Comparative Effectiveness of Best Practice Alerts with Active and Passive Presentations: A Retrospective StudyProceedings of the International Symposium on Human Factors and Ergonomics in Health Care, 2020
- Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective EndocarditisJAMA Internal Medicine, 2020
- Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018JAMA, 2020
- Oral versus Intravenous Antibiotics for Bone and Joint InfectionNew England Journal of Medicine, 2019
- Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support systemBMC Medical Informatics and Decision Making, 2017
- Switch over from intravenous to oral therapy: A concise overviewJournal of Pharmacology and Pharmacotherapeutics, 2014